Literature DB >> 16614109

Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.

Silvia Franceschi1, Maurizio Montella, Jerry Polesel, Carlo La Vecchia, Anna Crispo, Luigino Dal Maso, Pietro Casarin, Francesco Izzo, Luigi G Tommasi, Isabelle Chemin, Christian Trépo, Marina Crovatto, Renato Talamini.   

Abstract

Mortality rates of hepatocellular carcinoma (HCC) are high in Italy compared with other Western countries. To elucidate further the role of hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol drinking, and tobacco smoking in the etiology of HCC, we carried out a hospital-based case-control study in two areas of Italy: the province of Pordenone in the Northeast and the town of Naples in the South. A total of 229 HCC cases (median age, 66 years) and 431 controls (median age, 65 years) answered a questionnaire and provided blood samples between 1999 and 2002. Odds ratios (OR), percent attributable risks, and corresponding 95% confidence intervals were computed using unconditional multiple logistic regression. ORs for hepatitis B surface antigen (HBsAg) positive versus HBsAg negative and for anti-HCV antibody positive versus anti-HCV antibody negative were 20.2 and 15.6, respectively. Positivity for both markers was associated with an OR of 51.6. Sensitive molecular techniques applied to sera in a subset of HCC cases disclosed a very small number of occult hepatites. Maximal lifetime alcohol intake of > or =35 versus <7 drinks/wk was associated with an HBV/HCV adjusted OR of 5.9. Tobacco smoking was unrelated to HCC risk overall but seemed to enhance HCC risk among virus carriers. Overall, 61% of HCC were attributable to HCV, 13% to HBV, and 18% to heavy alcohol drinking. In conclusion, our study confirms the importance of HCV in HCC etiology in Italy where the widespread dissemination of the virus dates back four or five decades.

Entities:  

Mesh:

Year:  2006        PMID: 16614109     DOI: 10.1158/1055-9965.EPI-05-0702

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  42 in total

1.  Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis.

Authors:  Shu-Chun Chuang; Yuan-Chin Amy Lee; Mia Hashibe; Min Dai; Tongzhang Zheng; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

2.  Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy: Results from a joinpoint regression analysis.

Authors:  Anna Crispo; Maddalena Barba; Matteo Malvezzi; Grazia Arpino; Maria Grimaldi; Tiziana Rosso; Emanuela Esposito; Domenico Sergi; Gennaro Ciliberto; Antonio Giordano; Maurizio Montella
Journal:  Cancer Biol Ther       Date:  2013-09-09       Impact factor: 4.742

3.  The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2.

Authors:  Xiaoqin Lan; Fang Xiao; Qiang Ding; Jiqiao Liu; Jingmei Liu; Junhua Li; Jiong Zhang; De-An Tian
Journal:  J Mol Histol       Date:  2014-08-24       Impact factor: 2.611

4.  Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.

Authors:  Yue-Li Nan; Yan-Ling Hu; Zhi-Ke Liu; Fang-Fang Duan; Yang Xu; Shu Li; Ting Li; Da-Fang Chen; Xiao-Yun Zeng
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

5.  Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.

Authors:  Nagwa I Abdel-Hamid; Mona F El-Azab; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-09       Impact factor: 3.000

6.  Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India.

Authors:  Anil Arora; Praveen Sharma; Pankaj Tyagi; Vikas Singla; Veronica Arora; Naresh Bansal; Jay Toshniwal; Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2013-09-20

Review 7.  Managing chronic hepatitis C in the difficult-to-treat patient.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Liver Int       Date:  2007-12       Impact factor: 5.828

8.  Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma?

Authors:  Salvatore D'Angelo; Mario Secondulfo; Raffaele De Cristofano; Paolo Sorrentino
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

9.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

Authors:  Rohit Loomba; Hwai-I Yang; Jun Su; David Brenner; Elizabeth Barrett-Connor; Uchenna Iloeje; Chien-Jen Chen
Journal:  Am J Epidemiol       Date:  2013-01-24       Impact factor: 4.897

10.  Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.

Authors:  Paola Scognamiglio; Enrico Girardi; Mario Fusco; Pierluca Piselli; Silvana Russo Spena; Carmela Maione; Francesco Aurelio Pisanti; Diego Serraino
Journal:  BMC Infect Dis       Date:  2009-06-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.